Science Explorer Back to mapMap

Most cited papers from Victorian Infectious Diseases Reference Laboratory

Victorian Infectious Diseases Reference Laboratory

What are the most cited papers from Victorian Infectious Diseases Reference Laboratory?

The most cited paper from Victorian Infectious Diseases Reference Laboratory is "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" (Rafael Lozano et al., 2012), with 14,344 citations. Next come "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (12,027) and "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (9,055).

Showing 50 of 60 papers. Every paper with more than 295 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Rafael Lozano et al. · The Lancet Open access191 authors Dec 2012 14,344
2 A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Stephen S Lim et al. · The Lancet Open access209 authors Dec 2012 12,027
3 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Christopher J L Murray et al. · The Lancet Open access362 authors Dec 2012 9,055
4 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet Open access358 authors Dec 2012 8,461
5 The Global Burden of Cancer 2013 Christina Fitzmaurice et al. · JAMA Oncology Open access132 authors 28 May 2015 2,767
6 Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Shiv Kumar Sarin et al. · Hepatology International Open access 13 Nov 2015 2,603
7 The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro Leon Caly, Julian D Druce, Mike G Catton et al. · Antiviral Research Open access 3 Apr 2020 2,278
8 The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 Jeffrey D Stanaway et al. · The Lancet Open access 7 Jul 2016 1,388
9 Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews Paul K Nelson, Bradley M. Mathers, Benjamin Cowie et al. · The Lancet ReviewOpen access 29 Jul 2011 1,277
10 Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 Irani Thevarajan, Thi H. O. Nguyen, Marios Koutsakos et al. · Nature Medicine Open access 16 Mar 2020 1,107
11 Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Yun‐Fan Liaw, Jia‐Horng Kao, Teerha Piratvisuth et al. · Hepatology International 16 May 2012 1,042
12 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Christopher J L Murray et al. · The Lancet Open access366 authors 21 Jul 2014 998
13 Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆ Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini et al. · Gastroenterology Open access Jun 2004 916
14 Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Yun‐Fan Liaw, Nancy Leung, Jia‐Horng Kao et al. · Hepatology International Open access 9 May 2008 872
15 Hepatitis B virus infection Man‐Fung Yuen, Ding‐Shinn Chen, Geoffrey M Dusheiko et al. · Nature Reviews Disease Primers Review 6 Jun 2018 836
16 Statements from the Taormina expert meeting on occult hepatitis B virus infection Giovanni Raimondo et al. · Journal of Hepatology Aug 2008 834
17 The Global Circulation of Seasonal Influenza A (H3N2) Viruses Colin A. Russell et al. · Science 17 Apr 2008 758
18 Hepatitis B Virus Resistance to Nucleos(t)ide Analogues Fabien Zoulim, STEPHEN A LOCARNINI · Gastroenterology Open access 7 Sep 2009 710
19 A New Arenavirus in a Cluster of Fatal Transplant-Associated Diseases Gustavo F. Palacios, Julian D Druce, Lei Du et al. · New England Journal of Medicine Open access 6 Feb 2008 707
20 Global circulation patterns of seasonal influenza viruses vary with antigenic drift Trevor Bedford et al. · Nature Open access 8 Jun 2015 689
21 Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution Björn F. Koel, David F. Burke, Theo M. Bestebroer et al. · Science Open access 21 Nov 2013 677
22 SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe et al. · Journal of General Virology Open access 22 Jun 2020 643
23 Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium Josephine M. Bryant et al. · Science Open access 11 Nov 2016 603
24 Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm Melissa D. Simek et al. · Journal of Virology Open access 13 May 2009 599
25 Update of the statements on biology and clinical impact of occult hepatitis B virus infection Giovanni Raimondo et al. · Journal of Hepatology Open access 17 Apr 2019 574
26 Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Peter Angus, Rhys Vaughan, Shelly Xiong et al. · Gastroenterology Aug 2003 569
27 Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine Daniel J. Tenney, Steven M. LeVine, R.E. Rose et al. · Antimicrobial Agents and Chemotherapy Open access 24 Aug 2004 539
28 Antibody landscapes after influenza virus infection or vaccination Judith M. Fonville et al. · Science Open access 20 Nov 2014 526
29 A global scientific strategy to cure hepatitis B Peter A. Revill et al. · ˜The œLancet. Gastroenterology & hepatology Open access 10 Apr 2019 515
30 Molecular Virology of Hepatitis B Virus STEPHEN A LOCARNINI · Seminars in Liver Disease Feb 2004 514
31 RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg Christine I. Wooddell, Man‐Fung Yuen, Henry Lik‐Yuen Chan et al. · Science Translational Medicine Open access 27 Sep 2017 499
32 Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages David Stucki et al. · Nature Genetics Open access 31 Oct 2016 494
33 Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis Akosua Adom Agyeman, Ken Lee Chin, Cornelia B. Landersdorfer et al. · Mayo Clinic Proceedings ReviewOpen access 6 Jun 2020 478
34 Antiviral drug-resistant HBV Anna S. Lok, Fabien Zoulim, STEPHEN A LOCARNINI et al. · Hepatology Open access 27 Jun 2007 449
35 Global Phylogeny ofMycobacterium tuberculosisBased on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set Ingrid Filliol et al. · Journal of Bacteriology Open access 29 Dec 2005 437
36 Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998 Betty Ann Brown, M. Steven Oberste, James P. Alexander et al. · Journal of Virology Open access Dec 1999 433
37 Overview of hepatitis B viral replication and genetic variability Shuping Tong, Peter A. Revill · Journal of Hepatology Open access Apr 2016 431
38 Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers Alexander J. V. Thompson, Tin Quang Nguyen, David M. Iser et al. · Hepatology Open access Feb 2010 410
39 New hepatitis viruses: Contenders and pretenders Scott Bowden · Journal of Gastroenterology and Hepatology Open access Feb 2001 409
40 Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis Manzour Hernando Hazbón, Michael B Brimacombe, Miriam Bobadilla del Valle et al. · Antimicrobial Agents and Chemotherapy Open access 26 Jul 2006 388
41 The role of quantitative hepatitis B surface antigen revisited Markus Cornberg, Vincent Wai‐Sun Wong, STEPHEN A LOCARNINI et al. · Journal of Hepatology 2 Sep 2016 386
42 Perinatal transmission of hepatitis B virus: an Australian experience Elke Wiseman, Melissa A. Fraser, Sally Holden et al. · The Medical Journal of Australia May 2009 380
43 A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community Trang T. Vu, STEPHEN J. FARISH, Mark A. Jenkins et al. · Vaccine Review Mar 2002 378
44 Structural organization of the hepatitis B virus minichromosome C.–Thomas Bock, Susanne Schwinn, Stephen Locarnini et al. · Journal of Molecular Biology Mar 2001 368
45 Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use Arnold S. Monto, Jennifer L. McKimm‐Breschkin, Catherine A. Macken et al. · Antimicrobial Agents and Chemotherapy 26 Jun 2006 365
46 Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia Leon Caly, Julian D Druce, Jason Alexander Roberts et al. · The Medical Journal of Australia Open access Apr 2020 351
47 Hepatitis B Virus Epidemiology Jennifer H MacLachlan, B. C. Cowie · Cold Spring Harbor Perspectives in Medicine Open access May 2015 349
48 Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia Tin Quang Nguyen, Alexander J. V. Thompson, Scott Bowden et al. · Journal of Hepatology 17 Feb 2010 348
49 Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Kumar Visvanathan, Narelle A. Skinner, Alexander J. V. Thompson et al. · Hepatology 22 Dec 2006 340
50 Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2 Georgina Paizis, Christos Tikellis, Mark Emmanuel Cooper et al. · Gut Open access 15 Sep 2005 339

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.